Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
September 22, 2017
Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects
Peter Corcoran, David A Hollander, George W Ousler, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
February 5, 2013
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
Paulo J Gomes, George W Ousler, Donna L Welch, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 11, 2005
Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy
William Berger, Mark B Abelson, Paulo J Gomes, et al.
Clinical Therapeutics
|
October 22, 2009
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children
Mark B Abelson, Gail L Torkildsen, Jon I Williams, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 21, 2010
Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge
Gail L Torkildsen, Jon I Williams, James A Gow, et al.
Cornea
|
June 16, 2015
Optimizing Reading Tests for Dry Eye Disease
George W Ousler, John D Rodriguez, Lisa M Smith, et al.
Cornea
|
June 5, 2016
Diurnal Tracking of Blink and Relationship to Signs and Symptoms of Dry Eye
John D Rodriguez, Keith J Lane, George W Ousler, et al.
Current Medical Research and Opinion
|
June 23, 2005
Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis
Mark B Abelson, Paul J Gomes, Cullen T Vogelson, et al.
American Journal of Ophthalmology
|
May 22, 2010
Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis
Thomas T Macejko, Mark T Bergmann, Jon I Williams, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
June 9, 2011
Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis
Jon I Williams, Kathryn S Kennedy, James A Gow, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
September 22, 2017
Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects
Peter Corcoran, David A Hollander, George W Ousler, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
February 5, 2013
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
Paulo J Gomes, George W Ousler, Donna L Welch, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 11, 2005
Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy
William Berger, Mark B Abelson, Paulo J Gomes, et al.
Clinical Therapeutics
|
October 22, 2009
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children
Mark B Abelson, Gail L Torkildsen, Jon I Williams, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 21, 2010
Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge
Gail L Torkildsen, Jon I Williams, James A Gow, et al.
Cornea
|
June 16, 2015
Optimizing Reading Tests for Dry Eye Disease
George W Ousler, John D Rodriguez, Lisa M Smith, et al.
Cornea
|
June 5, 2016
Diurnal Tracking of Blink and Relationship to Signs and Symptoms of Dry Eye
John D Rodriguez, Keith J Lane, George W Ousler, et al.
Current Medical Research and Opinion
|
June 23, 2005
Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis
Mark B Abelson, Paul J Gomes, Cullen T Vogelson, et al.
American Journal of Ophthalmology
|
May 22, 2010
Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis
Thomas T Macejko, Mark T Bergmann, Jon I Williams, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
June 9, 2011
Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis
Jon I Williams, Kathryn S Kennedy, James A Gow, et al.
Page
of 7